Sipai Health Technology Co,

Sipai Health Technology Co, Debt

The Debt of Sipai Health Technology Co, (314.HK) as of Nov 21, 2026 is 45.49 M CNY. In the previous year, Debt was 67.56 M CNY — a change of -32.66% (lower).

Debt

45.49 MCNY

YoY

-32.66%

Last updated:

In 2024, Sipai Health Technology Co,'s total debt was 45.49 M CNY, a -32.66% change from the 67.56 M CNY total debt recorded in the previous year.

The Sipai Health Technology Co, Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2020
3.68 B CNY
Jan 1, 2021
7.52 B CNY
Jan 1, 2022
67.76 M CNY
Jan 1, 2023
67.56 M CNY
Jan 1, 2024
45.49 M CNY
The Sipai Health Technology Co, Debt history
YEARDebtYoY
45.49 MCNY-32.66%
67.56 MCNY-0.31%
67.76 MCNY-99.10%
7.52 BCNY+104.27%
3.68 BCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sipai Health Technology Co, Stock analysis

What does Sipai Health Technology Co, do? Sipai Health Technology Co., Ltd. generates revenue through its Specialty Pharmacy Business, which operates offline specialty pharmacies and distributes pharmaceutical products to pharmaceutical companies and distributors. The Physician Research Assistance Business offers integrated services to pharmaceutical companies for producing clinical trial data that meets regulatory standards, supporting their progression to later clinical phases or regulatory approvals. The Health Insurance Services Business provides insurance brokerage services, distributing various health and life insurance products on behalf of insurance carriers. These segments collectively serve pharmaceutical companies, healthcare providers, and insurance carriers through specialized offerings in pharmacy distribution, clinical research support, and insurance brokerage. The company's Specialty Pharmacy Business focuses on offline pharmacy operations and pharmaceutical distribution, targeting pharmaceutical companies and distributors as key clients. Physician Research Assistance Business caters to pharmaceutical companies requiring regulatory-compliant clinical trial data for advancing drug development. Health Insurance Services Business partners with insurance carriers to distribute health and life insurance products to end customers, leveraging the company's brokerage platform for insurance product distribution. Sipai Health Technology's business model integrates pharmacy distribution, clinical research support, and insurance brokerage to address specific needs within the healthcare sector. The Specialty Pharmacy Business serves pharmaceutical companies and distributors with offline pharmacy networks and product distribution. Physician Research Assistance Business assists pharmaceutical companies in meeting regulatory requirements for clinical trials, while Health Insurance Services Business facilitates insurance product distribution through brokerage partnerships with carriers. Sipai Health Technology Co, is one of the most popular companies on Eulerpool.

Debt Details

Understanding Sipai Health Technology Co,'s Debt Structure

Sipai Health Technology Co,'s total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Sipai Health Technology Co,'s debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Sipai Health Technology Co,’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Sipai Health Technology Co,’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Sipai Health Technology Co, stock

Debt of Sipai Health Technology Co, is 45.49 M CNY in 2024.

Debt of Sipai Health Technology Co, changed from 67.56 M CNY to 45.49 M CNY, representing a -32.66% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Sipai Health Technology Co, since 2006 – with annual values, charts, and detailed analysis.

Debt's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Sipai Health Technology Co, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sipai Health Technology Co,

All Key Metrics — Sipai Health Technology Co,